Serina Therapeutics SER SEC Filings

NYSE SER
$2.43 -0.14 (-5.41%)
As of: Sep 10, 2026 · 2:08 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Serina Therapeutics, Inc. (SER) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index